RSK3-MAKAP TARGETING AS A NEW THERAPEUTIC STRATEGY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION IN WOMEN

$1,281,479FY2018Department of the ArmyDOD

University Of Missouri System, Columbia MO

Investigators